During the past decade, The Second Affiliated Hospital of Shantou University Medical College conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Affiliated Hospital of Shantou University Medical College" #1 sponsor was "Chinese Academy of Medical Sciences, Fuwai Hospital" with 2 trials, followed by "Chipscreen Biosciences, Ltd." with 1 trials sponsored, "Guangdong Provincial People's Hospital" with 1 trials sponsored, "Lepu Medical Technology (Beijing) Co., Ltd." with 1 trials sponsored and "Peking University Third Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Shantou University Medical College" #1 collaborator was "Central South University" with 2 trials as a collaborator, "Ankang City Central Hospital" with 1 trials as a collaborator, "Beihua University" with 1 trials as a collaborator, "Beijing Chuiyangliu Hospital(Beijing Minimally Invasive Hospital)" with 1 trials as a collaborator and "Beijing Shijitan Hospital,the 9th Clinical Medical College of Peking university" with 1 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Shantou University Medical College" are "Hypertension" (2 trials), "Adverse Drug Reaction" (1 trials), "Cinepazide" (1 trials), "Coronary Heart Disease" (1 trials) and "ST-segment Elevation Myocardial Infarction (STEMI)" (1 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Shantou University Medical College" in a lesser frequency.

Most popular intervention types in "The Second Affiliated Hospital of Shantou University Medical College" are "Biological" (2 trials), "Drug" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "FMT capsules" (2 trials), "Placebo capsules" (2 trials), "Chiglitazar" (1 trials), "Dual anti-platelet therapy" (1 trials) and "Single anti-platelet therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Second Affiliated Hospital of Shantou University Medical College" are 6 trials for "All" genders.

Currently, there are NaN active trials in "The Second Affiliated Hospital of Shantou University Medical College". 2 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Second Affiliated Hospital of Shantou University Medical College, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Second Affiliated Hospital of Shantou University Medical College, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".